NCT00482417已完成2 期
Efficacy and Safety Study of MK0359 in Patients With Arthritis (0359-017)
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 11
研究概览
简要总结
Efficacy and Safety Study of MK0359 in Patients with Arthritis
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •You are 18-65 years of age and have Rheumatoid Arthritis
- •You must be able to read and understand patient questionnaires
排除标准
- •You have had certain types of surgery, certain types of cancer or history of Tuberculosis (TB) or HIV.
研究者
相似试验
已完成
2 期
A Study of MK0359 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0359-016)Pulmonary Disease, Chronic ObstructiveNCT00482235Merck Sharp & Dohme LLC45
终止
2 期
Safety and Preliminary Efficacy of MK0759 in Postherpetic Neuralgia (PHN)(0759-004)Neuralgia, PostherpeticNCT00245544Merck Sharp & Dohme LLC20
已完成
2 期
A Study of Safety and Efficacy of MK0859 (Anacetrapib) in Japanese Patients With Dyslipidemia (0859-029)DyslipidemiaNCT00977288Merck Sharp & Dohme LLC408
已完成
3 期
Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) InhibitorsArthritis, RheumatoidNCT00960440Pfizer399
终止
2 期
Treatment of Refractory Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea/Hypopnea Syndrome (OSA/HS) Using Nasal Continuous Positive Airway Pressure (nCPAP) Therapy (0249-015)Sleep Apnea, ObstructiveHypopnea SyndromeExcessive Daytime SleepinessNCT00620659Merck Sharp & Dohme LLC125